1. Home
  2. BOF vs FLNA Comparison

BOF vs FLNA Comparison

Compare BOF & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$2.02

Market Cap

56.3M

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

BUY

Current Price

$0.65

Market Cap

61.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BOF
FLNA
Founded
2017
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.3M
61.8M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
BOF
FLNA
Price
$2.02
$0.65
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
81.0K
★ 702.8K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.33
N/A
EPS
★ N/A
N/A
Revenue
$3,184,018.00
★ $41,119,000.00
Revenue This Year
$15.23
N/A
Revenue Next Year
$100.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.20
N/A
52 Week Low
$1.77
$0.64
52 Week High
$5.25
$2.03

Technical Indicators

Market Signals
Indicator
BOF
FLNA
Relative Strength Index (RSI) 17.93 34.93
Support Level N/A N/A
Resistance Level $4.13 $1.05
Average True Range (ATR) 0.34 0.04
MACD -0.10 -0.02
Stochastic Oscillator 10.55 3.74

Price Performance

Historical Comparison
BOF
FLNA

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients. The products are mainly sold through three channels: branded retail snack products, private label products for retailers, and fruit and vegetable ingredients sold to food manufacturers.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: